{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:51:38Z","timestamp":1792511498693,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013276","name":"Interreg Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jvacx.2023.100306","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T06:26:23Z","timestamp":1681971983000},"page":"100306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Differences in non-positive intention to accept the COVID-19 booster vaccine between three countries in the cross-border region Meuse-Rhine Euroregion: The Netherlands, Belgium, and Germany"],"prefix":"10.1016","volume":"14","author":[{"given":"C\u00e9line J.A.","family":"van Bilsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Stabourlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrissy P.B.","family":"Moonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Brinkhues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefaan","family":"Demarest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle A.T.","family":"Hanssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge H.M.","family":"van Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H.M.","family":"Savelkoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Philippsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte A.M.","family":"van der Zanden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole H.T.M.","family":"Dukers-Muijrers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian J.P.A.","family":"Hoebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jvacx.2023.100306_b0005","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.jvacx.2023.100306_b0010","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3390\/idr13040084","article-title":"COVID-19 Vaccine Booster: To Boost or Not to Boost","volume":"13","author":"Shekhar","year":"2021","journal-title":"Infect Dis Rep"},{"issue":"5","key":"10.1016\/j.jvacx.2023.100306_b0015","doi-asserted-by":"crossref","first-page":"2062983","DOI":"10.1080\/21645515.2022.2062983","article-title":"Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: A systematic review","volume":"18","author":"Du","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jvacx.2023.100306_b0020","unstructured":"(EMA) EMA. ECDC-EMA statement on booster vaccination with Omicron adapted bivalent COVID-19 vaccines 2022 [updated September 6th 2022; cited 2022 September 14th]. Available from: https:\/\/www.ema.europa.eu\/en\/news\/ecdc-ema-statement-booster-vaccination-omicron-adapted-bivalent-covid-19-vaccines."},{"key":"10.1016\/j.jvacx.2023.100306_b0025","doi-asserted-by":"crossref","DOI":"10.54724\/lc.2022.e5","article-title":"Vaccine strategy against COVID-19 with a focus on the Omicron and stealth Omicron variants: Life Cycle Committee Recommendations","author":"Smith","year":"2022","journal-title":"Life Cycle"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100306_b0030","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-022-31441-x","article-title":"Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021","volume":"13","author":"Lazarus","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.jvacx.2023.100306_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10030481","article-title":"Willingness to Receive COVID-19 Booster Vaccine: Associations between Green-Pass, Social Media Information, Anti-Vax Beliefs, and Emotional Balance","volume":"10","author":"De Giorgio","year":"2022","journal-title":"Vaccines"},{"issue":"11","key":"10.1016\/j.jvacx.2023.100306_b0040","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3390\/vaccines9111286","article-title":"Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland","volume":"9","author":"Rzymski","year":"2021","journal-title":"Vaccines"},{"issue":"12","key":"10.1016\/j.jvacx.2023.100306_b0045","article-title":"Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional Study","volume":"9","author":"Yadete","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jvacx.2023.100306_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2022.100317","article-title":"Predictors of uncertainty and unwillingness to receive the COVID-19 booster vaccine: An observational study of 22,139 fully vaccinated adults in the UK","volume":"14","author":"Paul","year":"2022","journal-title":"The Lancet Regional Health - Europe"},{"key":"10.1016\/j.jvacx.2023.100306_b0055","first-page":"18","article-title":"Willingness to receive an annual COVID-19 booster vaccine in the German-speaking D-A-CH region in Europe: A cross-sectional study","author":"Weitzer","year":"2022","journal-title":"The Lancet Regional Health \u2013 Europe"},{"issue":"2","key":"10.1016\/j.jvacx.2023.100306_b0060","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1093\/geronb\/gbaa074","article-title":"Age Differences in COVID-19 Risk Perceptions and Mental Health: Evidence From a National U.S. Survey Conducted in March 2020","volume":"76","author":"Bruine de Bruin","year":"2020","journal-title":"J Gerontol: Ser B"},{"key":"10.1016\/j.jvacx.2023.100306_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.911518","article-title":"Willingness and Perceptions Regarding COVID-19 Vaccine Booster Dose in Pakistani Vaccinated Population: A Cross-Sectional Survey","volume":"10","author":"Moeed","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.jvacx.2023.100306_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.841013","article-title":"Impacts and Lessons Learned of the First Three COVID-19 Waves on Cross-Border Collaboration in the Field of Emergency Medical Services and Interhospital Transports in the Euregio-Meuse-Rhine: A Qualitative Review of Expert Opinions","volume":"10","author":"Sommer","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.jvacx.2023.100306_b0075","unstructured":"covid-vaccinatie.be. Covid Vaccinaties Belgi\u00eb 2022 [updated September 10th, 2022; cited 2022 September 14th]. Available from: https:\/\/covid-vaccinatie.be\/nl."},{"key":"10.1016\/j.jvacx.2023.100306_b0080","unstructured":"Institut RK. Digitales Impfquotenmonitoring zur COVID-19-Impfung 2022 [updated September 14th, 2022; cited 2022 September 14th]. Tabelle mit den gemeldeten Impfungen nach Bundesl\u00e4ndern und Impfquoten nach Altersgruppen]. Available from: https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Daten\/Impfquoten-Tab.html."},{"key":"10.1016\/j.jvacx.2023.100306_b0085","unstructured":"Rijksoverheid. COVID-19-vaccinaties in Zuid-Limburg 2022 [updated September 4th, 2022; cited 2022 September 14th]. Available from: https:\/\/coronadashboard.rijksoverheid.nl\/veiligheidsregio\/VR24\/vaccinaties."},{"key":"10.1016\/j.jvacx.2023.100306_b0090","unstructured":"Organization WH. Ten threats to global health in 2019 2019 [cited 2022 September 7th]. Available from: https:\/\/www.who.int\/news-room\/spotlight\/ten-threats-to-global-health-in-2019."},{"issue":"6","key":"10.1016\/j.jvacx.2023.100306_b0095","doi-asserted-by":"crossref","first-page":"e048172","DOI":"10.1136\/bmjopen-2020-048172","article-title":"Public acceptance of COVID-19 vaccines: cross-national evidence on levels and individual-level predictors using observational data","volume":"11","author":"Lindholt","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jvacx.2023.100306_b0100","unstructured":"National Institute for Public Health and the Environment - Ministry of Health WaS. Variants of the coronavirus SARS-CoV-2 2022 [updated July 15th]. Available from: https:\/\/www.rivm.nl\/en\/coronavirus-covid-19\/virus\/variants."},{"key":"10.1016\/j.jvacx.2023.100306_b0105","unstructured":"(RIVM). Tijdlijn van coronamaatregelen [updated June 21st, 2022]. Available from: https:\/\/www.rivm.nl\/gedragsonderzoek\/tijdlijn-maatregelen-covid."},{"key":"10.1016\/j.jvacx.2023.100306_b0110","unstructured":"RIVM. Boostervaccinatie zeer effectief tegen ernstige COVID-19 2022 [updated January 19th; cited July 15th 2022]. Available from: https:\/\/www.rivm.nl\/covid-19-vaccinatie\/vaccineffectiviteit\/boostervaccinatie-zeer-effectief-tegen-ernstige-covid-19."},{"key":"10.1016\/j.jvacx.2023.100306_b0115","unstructured":"Rijksoverheid. Voor de jaarwisseling ruim 3 miljoen boosterprikken 2021 [updated December 12th; cited 2022 July 15th ]. Available from: https:\/\/www.rijksoverheid.nl\/actueel\/nieuws\/2021\/12\/03\/voor-de-jaarwisseling-ruim-3-miljoen-boosterprikken#:\u223c:text=Vanaf%20januari%20kan%20iedereen%2C%20in,vrijdag%20aan%20de%20Tweede%20Kamer."},{"key":"10.1016\/j.jvacx.2023.100306_b0120","unstructured":"Nordrhein-Westfalen DL. Current Corona Rules in North Rhine-Westphalia 2021 [cited 2022 July 15th]. Available from: https:\/\/www.land.nrw\/corona-multilingual#005d62f9."},{"key":"10.1016\/j.jvacx.2023.100306_b0125","unstructured":"Institut RK. STIKO: 14. Aktualisierung der COVID-19-Impfempfehlung 2021 [updated November 29th cited 2022 July 15th ]. Available from: https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2021\/48\/Art_01.html."},{"key":"10.1016\/j.jvacx.2023.100306_b0130","unstructured":"Institut RK. STIKO: 12. Aktualisierung der COVID-19-Impfempfehlung 2021 [updated October 18th cited 2022 July 15th ]. Available from: https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2021\/43\/Art_01.html."},{"key":"10.1016\/j.jvacx.2023.100306_b0135","unstructured":"info-coronavirus.be. Overlegcomit\u00e9 - vanaf 1 september vallen heel wat beperkingen weg 2021 [updated August 20th] Available from: https:\/\/www.info-coronavirus.be\/nl\/news\/occ-2008\/#:\u223c:text=Vanaf%201%20september%20is%20het,200%20toeschouwers%20binnen%20en%20400."},{"key":"10.1016\/j.jvacx.2023.100306_b0140","unstructured":"info-coronavirus.be. Overlegcomit\u00e9 - mondmaskerplicht, Covid Safe Ticket en telewerk in strijd tegen herfstgolf 2021 [updated October 26th. Available from: https:\/\/www.info-coronavirus.be\/nl\/news\/occ-2610\/."},{"key":"10.1016\/j.jvacx.2023.100306_b0145","unstructured":"Info-coronavirus.be. Versnelling van de vaccinatiecampagne door boostervaccin vanaf vier maanden na tweede prik 2021 [updated December 16th cited 2022 July 15th]. Available from: https:\/\/www.info-coronavirus.be\/nl\/news\/versnelling-booster\/."},{"key":"10.1016\/j.jvacx.2023.100306_b0150","unstructured":"Federale overheidsdienst volksgezondheid vvdvel. IMC Volksgezondheid 2021 [updated November 27th; cited 2022 July 15th ]. Available from: https:\/\/www.health.belgium.be\/nl\/news\/imc-volksgezondheid-19."},{"key":"10.1016\/j.jvacx.2023.100306_b0155","doi-asserted-by":"crossref","unstructured":"Stabourlos C, Bilsen CJA, Brinkhues S, Moonen CPB, Demarest S, Hanssen DAT, et al. COVID-19 pandemic response in the Meuse-Rhine Euroregion: Sampling, design and participation of a longitudinal cross-border study [Preprint] 2022; 10.21203\/rs.3.rs-1522262\/v1.","DOI":"10.21203\/rs.3.rs-1522262\/v1"},{"issue":"12","key":"10.1016\/j.jvacx.2023.100306_b0160","doi-asserted-by":"crossref","first-page":"e0243523","DOI":"10.1371\/journal.pone.0243523","article-title":"Behavioral measures to fight COVID-19: An 8-country study of perceived usefulness, adherence and their predictors","volume":"15","author":"Margraf","year":"2020","journal-title":"PLoS One"},{"issue":"33","key":"10.1016\/j.jvacx.2023.100306_b0165","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1016\/j.vaccine.2021.05.069","article-title":"Willingness to get vaccinated against Covid-19 and attitudes toward vaccination in general","volume":"39","author":"Kessels","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100306_b0170","doi-asserted-by":"crossref","first-page":"e08699","DOI":"10.1016\/j.heliyon.2021.e08699","article-title":"Fear of COVID-19, compliance with recommendations against virus transmission, and attitudes towards vaccination in Sweden","volume":"8","author":"H\u00e5kansson","year":"2022","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.jvacx.2023.100306_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10030464","article-title":"COVID-19 Vaccine Booster Hesitancy among Healthcare Workers: A Retrospective Observational Study in Singapore","volume":"10","author":"Koh","year":"2022","journal-title":"Vaccines"},{"issue":"6","key":"10.1016\/j.jvacx.2023.100306_b0180","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s10900-021-00984-3","article-title":"The Nature and Extent of COVID-19 Vaccination Hesitancy in Healthcare Workers","volume":"46","author":"Biswas","year":"2021","journal-title":"J Community Health"},{"issue":"5","key":"10.1016\/j.jvacx.2023.100306_b0185","article-title":"Factors Influencing the Acceptance of COVID-19 Vaccines in a Country with a High Vaccination Rate","volume":"10","author":"Toro-Ascuy","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"10334","key":"10.1016\/j.jvacx.2023.100306_b0190","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(22)00172-6","article-title":"Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021","volume":"399","author":"Bollyky","year":"2022","journal-title":"Lancet"},{"issue":"10303","key":"10.1016\/j.jvacx.2023.100306_b0195","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(21)01808-0","article-title":"Towards a European strategy to address the COVID-19 pandemic","volume":"398","author":"Priesemann","year":"2021","journal-title":"Lancet"},{"issue":"10225","key":"10.1016\/j.jvacx.2023.100306_b0200","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0140-6736(20)30461-X","article-title":"How to fight an infodemic","volume":"395","author":"Zarocostas","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jvacx.2023.100306_b0205","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.201199","article-title":"Susceptibility to misinformation about COVID-19 around the world","volume":"7","author":"Roozenbeek","year":"2020","journal-title":"R Soc Open Sci"},{"issue":"18","key":"10.1016\/j.jvacx.2023.100306_b0210","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.vaccine.2017.03.013","article-title":"Lower vaccine uptake amongst older individuals living alone: A systematic review and meta-analysis of social determinants of vaccine uptake","volume":"35","author":"Jain","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2023.100306_b0215","unstructured":"RIVM. Redenen om alsnog te laten vaccineren 2022 [updated February 2nd]. Available from: https:\/\/www.rivm.nl\/gedragsonderzoek\/redenen-om-alsnog-te-laten-vaccineren."},{"key":"10.1016\/j.jvacx.2023.100306_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(22)00278-9","article-title":"Why we still need a pandemic treaty","author":"Hannon","year":"2022","journal-title":"The Lancet Global Health"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136223000475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136223000475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:29:47Z","timestamp":1792510187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136223000475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":44,"alternative-id":["S2590136223000475"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2023.100306","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in non-positive intention to accept the COVID-19 booster vaccine between three countries in the cross-border region Meuse-Rhine Euroregion: The Netherlands, Belgium, and Germany","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2023.100306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100306"}}